Skip to content

CS-BreastCancer HER2

by Cells Ia Technologies S.L. EUDAMED

Active European Union

Ref CS-BreastCancer HER2 V0.0.0Model CS-BreastCancer HER2 v0.0.0

Regulatory status

as of 27 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-08437027144127 Basic UDI-DIDate7 Oct 2025RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

European Union — CE/IVDD Expiring

Certificates: none listed in EUDAMED

Specification

EUDAMED

Model / Reference
CS-BreastCancer HER2 v0.0.0
Primary DI / UDI-DI
08437027144127
Basic UDI-DI
B-08437027144127
EMDN Code
W0202050392 Laboratory instruments for microscopic investigations - IVD medical device software
Device Class
Class IVD General
Special Device Type
-1202
Market of Registration
Spain

Manufacturer details

EUDAMED SRN
ES-MF-000042517

Other devices from Cells Ia Technologies S.L.

See all devices from Cells Ia Technologies S.L. →

Properties

  • Human Tissues

Other properties (9)

  • Sterile: No
  • Animal Tissues: No
  • Microbial Substances: No
  • Reagent: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Professional Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No